Semaglutide Injection
Semaglutide (GLP-1) is a glucagon-like peptide-1 receptor agonist studied for its role in regulating appetite, improving blood sugar control, and supporting weight management. Its ability to mimic natural GLP-1 activity offers exciting potential in metabolic and diabetes-related research.
On
Wednesday, December 10, 2025